Please login to the form below

Not currently logged in
Email:
Password:

Best Use of Data Visualisation *NEW FOR 2020*

Sponsored by:

2020 Finalists

SiGHT

by Bedrock Healthcare Communications for Novartis

Our client, the medical affairs lead for a peri- launch product in ophthalmology, recognised that to convey scientific messages and clinical trial insights quickly and effectively to healthcare professionals (HCPs), her Medical Scientific Liaisons (MSLs) from across the globe had to be confident in explaining complex data from two pivotal clinical trials with intricate study designs. Messaging had to be consistent, the scientific narrative understood, and each country had to be able to tailor the data story to the needs of its local market.

We looked at innovative ways of explaining data that moved away from traditional core slide decks, to enable MSLs to engage effectively with busy HCPs in-clinic. To design a solution that served the local markets well and effectively conveyed insights from the trial data clearly, we worked with members of medical teams globally to outline the potential of data visualisation and developed an iPad-based tool that met all their key challenges.

The tool was named SiGHT and is now in use in over eight countries across the globe. Content has been translated into local languages, bringing data to life on a daily basis by supporting HCP/MSL conversations at the local level.

Suspicion of Sepsis Dashboard and Atrial Fibrillation (AF)

by OPEN VIE for Imperial College Health Partners

It’s widely accepted that we won’t overcome the challenges of the NHS if we don’t make the most of real-world data. Fifteen years ago an NHS Confederation report into healthcare variation suggested that Hospital Episode Statistics (HES) data could be key to improving the quality of NHS care. The recommendation has aged well. Today, as pressure on healthcare resources intensifies, HES is at the heart of a wide range of quality improvement programmes to reduce avoidable variation and enhance patient outcomes.

The Suspicion of Sepsis (SOS) Insights Dashboard which was developed collaboratively by Imperial College Health Partners (ICHP), Data partners Harvey Walsh trading as OPEN VIE and NHS Improvement and NHS England – gives NHS staff reliable data to monitor and evaluate the impact of interventions on deteriorating patients with a suspicion of sepsis.

The SOS dashboard – which adopts an innovative coding method that mitigates inaccuracies and inconsistencies inherent in previous approaches – visualises HES, showing clinical data, trends and insights at hospital, regional and national levels. Now rolled out nationally and included in the NHS Long Term Plan, it’s facilitating better planning of pathways and a more focused application and measurement of initiatives that reduce the burden of sepsis.

Vagal Nerve Stimulation – Presenting Complex RWD in an Impactful Way

by OPEN VIE for LivaNova PLC

LivaNova approached OPEN VIE to discuss the inequality across England in access to Vagus Nerve Stimulation (VNS) Therapy to treat patients with epilepsy. Alongside this it was also deemed important to look at the outcomes of patients post-VNS therapy and monitor the healthcare resource utilisation of these patients post the initial implantation.

OPEN VIE then worked in partnership to build a real-world analysis based on Hospital Episode Statistics to look at variations and outcomes. Subsequent to the initial model, OPEN VIE created a series of related dashboards that are utilised to describe the local variations in treatment and the local outcomes based on effective patient management.

The dashboards are specifically designed to translate very complex analysis into a simple, visually engaging discussion flow to support the improvement of patient outcomes in England. The key to the success of the dashboards is that they can be understood and utilised by non-data experts in order to maximise the effectiveness of the project.

The utilisation of these dashboards has improved patient access to treatment across the UK and has been used by the company and clinicians alike.

From Data to Policy Action: How Pfizer’s CTRL Cancer Partnership is Facilitating Policy Change to Improve Cancer Care in Central and Eastern Europe

by Porter Novelli for Pfizer Biopharmaceuticals Group/Oncology

Despite encouraging advances in science and technology, the cancer burden continues to rise in Central Eastern Europe (CEE). The CTRL Cancer initiative was created for Pfizer Oncology as a platform to engage CEE countries in a dialogue to improve their standards of cancer care.

The initiative has compiled rich data describing cancer care activities, policies and practices in 16 countries. Our challenge was how to get the most value from this data; to present compelling facts to health decision makers and patient organisations, encouraging them to create National Cancer Control Plans (NCCPs).

The solution was to establish a series of CTRL Cancer Country Dashboards to distil information in an easy-to-understand and visual format. These tools allow decision makers, advocates and cancer specialists to navigate easily large sets of published data, identify gaps for policy action and compare data with other CEE countries. Another innovative aspect of the dashboards was their co-creation process whereby country champions and international cancer policy leaders were consulted to review their relevance to countries’ needs.

The dashboards are contributing to significant policy outcomes. Ukrainian partners used them at their National Cancer Policy Forum (2020), visualising Ukraine’s situation for decision makers and comparing it to other countries. The result: Parliament voted to unlock funds for a National Cancer Control Plan in 2021.

Executive summaries as submitted.

Back to full list

Category Sponsors

Contact information:

For sponsorship opportunities:
Sales Team
sales@pmlive.com
Tel: +44 (0)1372 414200

General event enquiries:
Debbie Tuesley
dtuesley@pmlive.com
Tel: +44 (0)1372 414243